0001209191-19-024175.txt : 20190409
0001209191-19-024175.hdr.sgml : 20190409
20190409185906
ACCESSION NUMBER: 0001209191-19-024175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190405
FILED AS OF DATE: 20190409
DATE AS OF CHANGE: 20190409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soteropoulos Paula
CENTRAL INDEX KEY: 0001692444
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 19740371
MAIL ADDRESS:
STREET 1: 49 WINONA STREET
CITY: PEABODY
STATE: MA
ZIP: 01960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-05
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001692444
Soteropoulos Paula
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
1
1
0
0
Chief Executive Officer
Common Stock
2019-04-05
4
M
0
30000
6.48
A
30000
D
Common Stock
2019-04-05
4
S
0
30000
32.11
D
0
D
Common Stock
2019-04-08
4
M
0
1787
6.48
A
1787
D
Common Stock
2019-04-08
4
S
0
1787
32.1658
D
0
D
Stock Option (right to buy)
6.48
2019-04-05
4
M
0
30000
0.00
D
2025-12-15
Common Stock
30000
1712866
D
Stock Option (right to buy)
6.48
2019-04-08
4
M
0
1787
0.00
D
2025-12-15
Common Stock
1787
1711079
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The weighted average sale price for the transaction reported was $32.1658, and the range of prices were between $32.11 and $32.20. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The shares vest as follows: 1/4th of the shares vest one year after January 1, 2015;1/48th of the shares vest monthly thereafter over the next three years.
/s/ Paula Soteropoulos
2019-04-09